BioengineeringRoadmapping Summit

March 5-7, 2018 at the
NASA Ames Research Park, Mountain View, California

The Bioengineering Road-mapping Summit gathers select leaders from multi-disciplinary fields to identify and characterize the challenges and enabling technologies ahead in engineering tissues and organs for patients in need. The Summit is the third in the New Organ Alliance’s series of events defining a Roadmap to Ending the Organ Shortage. The Summit is a participatory program with presentations providing background on the state-of-the-art in each area of the road-map set between three core roundtable discussions sessions that will engage all participants in detailed conversations to identify and characterize the challenges ahead and define potential enabling technologies that may accelerate solutions to organ impairment and disease.

Outcomes from this Summit include:

  1. Updating specific Challenge Topics, Sub-Challenges, and Enabling Technology Topics within the Roadmap to Ending the Organ Shortage.
  2. Identifying and characterizing ways in which potential enabling technologies may accelerate solutions to the specific bioengineering challenge topics.
  3. Accelerating innovative partnerships that could help solve the Vascular Tissue Challenge.
  4. Preparing the first public version of the Road-mapping Report and online database.
  5. Identifying potential challenge topics for future prize opportunities to be pursued through the New Organ Alliance.

If you are interested in participating in the Summit, but have not yet registered, please contact josh@competitionsciences.org for information on how to proceed.

For more information download the Summit Program Guide PDF Icon

Summit Agenda

March 5th

Opening Program and Reception

  • Welcome to NASA Ames
    • Dr. Steven Zornetzer, Associate Director, NASA Ames Research Center
  • Why NASA is Involved. An Introduction to NASA’s Centennial Challenges Program
    • Mrs. Monsi Roman, Program Manager, NASA Centennial Challenges Program
  • An Introduction to Bioengineering on the Space Station
    • Dr. Michael Roberts, Deputy Chief Scientist, CASIS
  • The Methuselah Foundation ‐ Investing to extend healthy life
    • Mr. David Gobel, CEO, Methuselah Foundation
  • Keynote on Enabling Technology (invited)

March 6th

Setting the Stage for Road-mapping

  • Introduction to the New Organ Alliance and Roadmap
    • Mr. Joshua Neubert, Managing Partner, New Organ Alliance
  • Vascular Tissue Challenge Presentation
    • Dr. Jordan Miller, Rice University
  • Vascular Tissue Challenge Presentation
    • Dr. Kunal Mitra, Florida Institute of Technology
  • Vascular Tissue Challenge Presentation
    • Dr. Ibrahim Ozbolat, Penn State University
  • Vascular Tissue Challenge Presentation
    • Dr. Eugene Boland, Techshot Inc.
  • Vascular Tissue Challenge Presentation
    • Dr. Melanie Matheu, Prellis Biologics
  • Vascular Tissue Challenge Presentation
    • Dr. Harald Ott, Harvard University, IVIVA Medical
  • Vascular Tissue Challenge Presentation
    • Miromatrix

Road-mapping Roundtables Part 1: Research strategies

  • Research Strategy Committee Chair Presentation
    • Dr. Scott Collins, 3D Bioprinting Committee Chair
  • Research Strategy Committee Chair Presentation
    • Dr. Armand Keating, In-Vivo Regeneration Committee Chair
  • Roundtable Discussions: Research Strategies

    Breakout discussions among participants on each research strategy to identify and characterize the challenges ahead and potential enabling technologies.

Road-mapping Roundtables Part 2: Organ Engineering Topics

  • Organ Engineering Committee Chair Presentation
    • Dr. Maria Rapoza, Cardiovascular Engineering Committee Chair
  • Organ Engineering Committee Chair Presentation
    • Dr. Mauris DeSilva, Muscle Engineering Committee Chair
  • Organ Engineering Committee Chair Presentation
    • Dr. Byron E. Petersen, Liver Engineering Committee Chair
  • Organ Engineering Committee Chair Presentation
    • Dr. Timothy Hammond, Kidney Engineering Committee Chair
  • Roundtable Discussions: Organ Engineering

    Breakout discussions among participants on each organ engineering topic to identify and characterize the challenges ahead and potential enabling technologies.

  • Roundtable Debrief Presentations

    Chairs or facilitators from each roundtable will present a debrief on their discussions and additions to the road-map.

Road-mapping Roundtables Part 3: Enabling Technologies

  • Enabling Technology Overview Presentations
    • Dr. Patricia Parsons-Wingerter, Vascular Patterning for Research Discovery and Tech. Dev.
  • Enabling Technology Overview Presentations
    • Dr. Michael Roberts / Ms. Jana Stoudemire, Microgravity Environment
  • Enabling Technology Overview Presentations
    • Dr. John Cumbers, Synthetic Biology
  • Enabling Technology Overview Presentations
    • Mr. Jedd Lewis / Dr. Kate Franz, Cryopreservation
  • Roundtable Discussions: Enabling Technologies

    Participants discuss the Enabling Technologies within their roundtables to identify and characterize the challenges ahead and potential road-map topic that can be accelerated.

  • Roundtable Debrief Presentations

    Chairs or facilitators from each roundtable will present a debrief on their discussions and additions to the road-map.

March 7th

Setting Up The Next Steps

  • Commercialization and Funding Strategies to Accelerate Bioengineering
    • Mr. Sergio Ruiz, Managing Partner, Methuselah Fund
  • Commercialization and Funding Strategies to Accelerate Bioengineering
    • Dr. Michele Grimm, National Science Foundation
  • Commercialization and Funding Strategies to Accelerate Bioengineering
    • Dr. Murray Sheldon, Food and Drug Administration, Kidney Innovation Accelerator
  • Communicating Science
    • Dr. Kiki Sanford, Co-Founder and Host, This Week In Science
  • Standardization
    • Dr. Gene Kopen, National Disease Research Interchange
  • Roadmap Review, Next Steps, and Closing Comments
    • Mr. Joshua Neubert, Managing Partner, New Organ Alliance